About G Square Capital
G Square Healthcare Private Equity LLP (operating as G Square Capital) is a pan-European private equity firm focused exclusively on mid-market healthcare companies across Europe, with investment activity spanning ten or more countries including the United Kingdom, France, Germany, the Nordics, and the broader Western and Eastern European markets, as well as selective activity in the Middle East. The firm targets companies across four core healthcare subsectors — medical products and devices (including surgical instruments, medical disposables, and pharmaceutical products), digital health and healthcare technology (encompassing healthcare IT, telehealth, artificial intelligence-enabled diagnostics, and health edtech), healthcare services (including specialized medical and surgical clinics, diagnostic services, and dental services), and services to the pharmaceutical industry (including contract research organizations, contract development and manufacturing organizations, and contract commercialization organizations) — committing €30 million to €60 million of equity per investment, with additional co-investment capacity from its limited partners. Transaction types include management buyouts, leveraged buyouts, growth capital financings, and secondary buyouts, with majority control as the standard ownership structure and biotech companies explicitly excluded from the firm's mandate. G Square applies a hands-on, board-level operational partnership approach alongside portfolio company management, drawing on a team with deep healthcare sector expertise to drive buy-and-build strategies, operational improvement, and geographic expansion. The firm is a signatory to the UN Principles for Responsible Investment and integrates ESG considerations throughout its investment process. Founded in 2008, the firm is headquartered in London, United Kingdom.